Physician profile
John C Wheeler
NPI 1073700928
$5,205.81
in general payments reported to CMS, 2019-2025
12 companies · $338 in 2025
The $338 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,522 · 2020: $1,756 · 2021: $814 · 2022: $292 · 2023: $53.96 · 2024: $430 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $822.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $821.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,801.04 | 2019-2025 | T2 Alpha, Gamma, Blueprint Patient Specific Instrumentation |
| Arthrex, INC. | $1,146.05 | 2020-2025 | |
| Impactortho, INC. | $740.64 | 2020-2025 | |
| Zimmer Biomet Holdings, INC. | $310.25 | 2022-2025 | Comprehensive Shoulder System, Affixus |
| Djo, LLC | $48.22 | 2022 | |
| Bioventus LLC | $47.35 | 2022-2024 | Durolane, Durolane |
| Orthofix Medical, INC. | $37.83 | 2021-2025 | Physio-Stim |
| Depuy Synthes Sales INC. | $20.90 | 2021 | |
| Smith+Nephew, INC. | $17.26 | 2023 | Trigen Intertan |
| Ethicon US, LLC | $15.16 | 2021 | |
| Abbott Laboratories | $13.02 | 2020 | |
| Dynasplint Systems INC. | $8.09 | 2023 | Dynasplint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Wheeler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.